Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 50 of 462
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
THEMED DISCUSSION LEADER
Nicole Frahm
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
LYMPH NODE HIV-SPECIFIC CXCR5+ CTLs ARE ASSOCIATED WITH ENHANCED VIRAL CONTROL
Zaza Ndhlovu
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
RESIDENT MEMORY CD8+ T CELLS FORM THE FRONT-LINE DEFENSE IN HIV-INFECTED LYMPH NODES
Marcus Buggert
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
HIV-1 ESCAPE FROM CD8+ CYTOTOXIC T-LYMPHOCYTES DEFINED AT CLONAL RESOLUTION
Aleksandr Gorin
University of California, Los Angeles, Los Angeles, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
INVESTIGATING THE ROLE OF TCR STRUCTURE IN FUNCTIONAL ACTIVITY OF HIV-SPECIFIC CTLS
Nina Campbell Flerin
Albert Einstein College of Medicine, Bronx, NY, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
HIV-SPECIFIC CD8 T CELLS IN PERSONS TREATED IN FIEBIG I ACUTE INFECTION WHO STOP ART
Hiroshi Takata
US Military HIV Research Program; HJF, Silver Spring, MD, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CD8 T CELLS: WHERE AND HOW THEY KILL
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
THEMED DISCUSSION LEADER
Andrea Howard
Columbia University, New York, NY, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
MIGRATION, GENDER, AND HIV INCIDENCE IN RAKAI, UGANDA
Oluwasolape M Olawore
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
OUTCOMES ALONG THE HIV CARE CONTINUUM AMONG UNDOCUMENTED IMMIGRANTS IN CLINICAL CARE
Jonathan Ross
Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
IMMIGRANTS AND BOTSWANA'S ART PROGRAM: POTENTIAL BARRIERS TO EPIDEMIC CONTROL
Tafireyi Marukutira
Macfarlane Burnet Inst For Med Res & Public Health, Melbourne, Australia
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
CASCADE OF CARE OF HIV SEROCONVERTERS IN THE CONTEXT OF UNIVERSAL “TEST AND TREAT”
Joseph Larmarange
Institut de Recherche pour le Développement (IRD), Paris, France
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV, MIGRATION, AND ACCESS TO CARE
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
THEMED DISCUSSION LEADER
John R. Koethe
Vanderbilt University Medical Center, Nashville, TN, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
BODY MASS INDEX AND THE RISK OF SERIOUS NON-AIDS EVENTS: THE D:A:D STUDY
Amit C Achhra
Kirby Institute, UNSW Australia; & NCB Hosp and JJP VA Med Ctr, New York, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
RANDOMIZED TRIAL OF BEHAVIORAL WEIGHT LOSS FOR HIV-INFECTED PATIENTS
Katie Becofsky
University of Massachusetts Amherst, Amherst, MA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
Predictors of Severe Weight/Body Mass Index Gain Following Antiretroviral Initiation
Priya Bhagwat
University of California, Los Angeles, Los Angeles, CA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
RALTEGRAVIR SWITCH AND BIOMARKERS OF LIVER STEATOSIS AND METABOLIC SYNDROME IN WOMEN
Jordan E Lake
University Texas Houston, Houston, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
CHANGES IN LIVER STEATOSIS AFTER SWITCHING EFAVIRENZ TO RALTEGRAVIR: THE STERAL STUDY
Juan Macías
Hospital Universitario de Valme, Sevilla, Spain
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: OBESITY AND FATTY LIVER DISEASE
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
THEMED DISCUSSION LEADER
Aaron S Siegler
Emory University Rollins School of Public Health, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
FEASIBILITY OF A PHARMACIST-RUN HIV PREP CLINIC IN A COMMUNITY PHARMACY SETTING
Elyse Tung
Kelley-Ross Pharmacy, Seattle, WA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
ASSESSING THE EFFICACY AND FEASIBILITY OF A RETAIL PHARMACY-BASED HIV TESTING PROGRAM
Bryan C Collins
Virginia Department of Health, Richmond, VA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
MIDWEST PHARMACISTS' KNOWLEDGE OF & WILLINGNESS TO PROVIDE PREEXPOSURE PROPHYLAXIS
Jordan Broekhuis
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
TEXT MESSAGING IS ASSOCIATED WITH IMPROVED RETENTION IN A CLINIC-BASED PREP PROGRAM
Christine M Khosropour
University of Washington, Seattle, WA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
BRIEF BEHAVIORAL INTERVENTION INCREASES PREP DRUG LEVELS IN A REAL-WORLD SETTING
Sarit A. Golub
Hunter College and Graduate Center, City University of New York, New York, NY, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: PREP WITHOUT BORDERS: NEW DELIVERY OPTIONS
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
THEMED DISCUSSION LEADER
Kate Bishop
The Francis Crick Institute, London, United Kingdom
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
UBP43 (USP18) ABROGATES SAMHD1-MEDIATED RESTRICTION OF HIV-1
Edmund Osei-Kuffour
Heinrich-Heine-University Hospital, Düsseldorf, Germany
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
LNCRNA DISCOVERY IN THE HIV REPLICATION CYCLE ADDS A NEW LAYER IN HIV-HOST INTERPLAY
Wim Trypsteen
HIV Cure Research Center, Ghent University, Ghent, Belgium
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
SPLICING IN A PANEL OF HIV-1 TRANSMITTED/FOUNDER VIRUSES
Ann Emery
University of North Carolina Chapel Hill, Durham, NC, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
THE ROLES OF 5 CONSERVED LENTIVIRAL RNA STRUCTURES IN HIV-1 REPLICATION
Yang Liu
National Cancer Institute, Frederick, MD, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
EXPONENTIAL GROWTH OF HIV DEPENDENT ON BURST SIZE BREAKTHROUGH OF THE ALLEE THRESHOLD
Jason M Hataye
National Institutes of Health, USA, Bethesda, MD, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: VIRUS AND CELL RNA IN HIV REPLICATION
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
THEMED DISCUSSION LEADER
Ned Sacktor
Johns Hopkins University, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
CAN WE AFFORD TO WAIT? ART AND THE CNS
Kevin Robertson
University of North Carolina - Chapel Hill, Chapel Hill, NC, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
COGNITIVE TRAJECTORIES OVER 4 YEARS AMONG HIV+ WOMEN WITH OPTIMAL VIRAL SUPPRESSION
Leah H Rubin
University of Illinois at Chicago, Chicago, IL, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
CENICRIVIROC IMPROVES NEUROCOGNITION AND REDUCES MONOCYTE ACTIVATION IN TREATED HIV
Michelle L D'Antoni
University of Hawaii, Honolulu, HI, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
CSF INFLAMMATORY MARKERS AFTER ADDING MARAVIROC TO MONOTHERAPY DARUNAVIR/RITONAVIR
Tristan Barber
Chelsea and Westminster NHS Foundation Trust, London, United Kingdom
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
EXTENSIVE EFAVIRENZ METABOLISM IS ASSOCIATED WITH GREATER CNS TOXICITY
Robert Gross
University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: CNS TREATMENT STRATEGIES: RISK AND BENEFITS
QUESTIONS AND ANSWERS
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
THEMED DISCUSSION LEADER
Thor Wagner
University of Washington & Seattle Children's, Seattle, WA, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
CLONAL EXPANSION OF GENOME-INTACT HIV-1 IN FUNCTIONALLY POLARIZED T-CELL SUBSETS
Guinevere Q. Lee
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
INTACT PROVIRUSES ARE UNEQUALLY DISTRIBUTED IN T CELL SUBSETS DURING ART
Bonnie Hiener
The Westmead Institute for Medical Research, University of Sydney, Westmead, Australia
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
A SMALL FRACTION OF PROVIRUSES IN EXPANDED CLONES EXPRESS UNSPLICED HIV RNA IN VIVO
Andrew Musick
NIH/NCI, Frederick, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
PROLIFERATION OF CD4+ T CELLS CONTAINING REPLICATION-COMPETENT HIV-1
Zheng Wang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV PERSISTENCE: CLONES, CLONES, AND MORE CLONES
CYTOTOXIC T LYMPHOCYTES MAY SHAPE THE HIV-1 PROVIRAL LANDSCAPE
Ya-Chi Ho
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV SELF-TESTING: KNOW YOURSELF
THEMED DISCUSSION LEADER
Joanne Stekler
University of Washington, Seattle, WA, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV SELF-TESTING: KNOW YOURSELF
HIV SELF-TEST (HIVST) AWARENESS, EXPOSURE, AND USE, NEW YORK CITY, 2015–2016
Paul M Salcuni
New York City Department of Health and Mental Hygiene, Queens, NY, USA
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
THEMED DISCUSSION: HIV SELF-TESTING: KNOW YOURSELF
PEER-LED ORAL HIV-SELF TESTING FINDS UNDIAGNOSED HIV AMONG MSM IN MALINDI, KENYA
Eduard Sanders
Kenya Medical Research Institute, Kilifi, Kenya, Kilifi, Kenya
from CROI 2017 on February 15, 2017 1:30 PM-2:30 PM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 7 8 9 10 presentations: 1 to 50 of 462